
    
      The first phase of this study will be to contact all subjects in the cohort by a mailing
      introducing them to the study. This will be followed by a phone call and administration of a
      questionnaire by phone or by mail. The questionnaire will collect current information on
      acromegaly treatment, morbidities other relevant history. Subjects will provide verbal
      consent to participate in this questionnaire part of the study and review of their medical
      records by the Principal Investigator (PI) and study staff.

      In the second phase of the study, subjects will be invited to come for a visit that will be
      conducted by the PI and study staff at the Pituitary Center of Columbia University Irving
      Medical Center. At this visit written informed consent will be obtained. The investigators
      will review the subjects' medical history that is obtained from the subject and review any
      records and laboratory test results provided by the subject and conduct clinical and
      laboratory assessments. Although all subjects participating in Phase 1 will be invited to
      participate, it is estimated that 120 of the subjects invited will come for the one visit
      over the 2-year time frame of this study.

      In the third phase of the study a chart review for collection will be conducted and all data
      will be compiled. All subjects agreeing to participate, both in person and by mail, a chart
      review of all relevant patient data including demographic, clinical, biochemical, surgical
      and follow up information. Data from questionnaires and record reviews will be compiled for
      analysis.
    
  